Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000950170-23-052700

Chief Accounting Officer sold 2,582 shares at $27.24 ($70,334)

  • Chief Accounting Officer acquired 2,582 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lyon Joseph Douglas Chief Accounting Officer 2023-10-06 Option exercise 10b5-1 +2,582 $11.35 $29,306 8,436 D
Lyon Joseph Douglas Chief Accounting Officer 2023-10-06 Sale 10b5-1 −2,582 $27.24 $70,334 5,854 D
Derivatives
Lyon Joseph Douglas Chief Accounting Officer 2023-10-06 Option exercise · Stock option (right to buy) 10b5-1 −2,582 54,167 D
Open-market sales · 2,582 sh · avg $27.24 · $70,334
Loading xslF345X05/ownership.xml…